Top View

1
RAS Signaling Targeted Cancer Therapy
Zhuoran QI, Xiaojing DU, Quanlin AN, Jinglin XIA, Xin CAO
2022, 1(1): 11-23. doi: 10.11910/j.issn.2791-3937.2022.20210001
[Abstract](1002) [FullText HTML] (451) [PDF 1630KB](53)
2
Inaugural Editorial: New Era, New Journal
Jia FAN
2022, 1(1): 1-2. doi: 10.11910/j.issn.2791-3937.2022.20220004
[Abstract](934) [FullText HTML] (461) [PDF 1277KB](62)
3
Modern Radiotherapy in the Multidisciplinary Management of Common Cancers
Shisuo DU, Yixing CHEN, Qian ZHANG, Jing SUN, Guifen MA, Jian WANG, Xian ZHANG, Taiwei SUN, Yang ZHANG, Jianying ZHANG, Qiqiao WU, Zhaochong ZENG
2022, 1(2): 81-94. doi: 10.11910/j.issn.2791-3937.2022.20220006
[Abstract](590) [FullText HTML] (275) [PDF 1400KB](43)
4
Prevalence and Clinical Implication of t(11;14) in Light-Chain Amyloidosis with or without Coexistent Multiple Myeloma in the Era of Proteasome Inhibitors
Tianhong XU, Zheng WEI, Jing LI, Jiadai XU, Yang YANG, Wenjing WANG, Jingli ZHUANG, Zhimei WANG, Lili JI, Luya CHENG, Weiguang WANG, Zhixiang CHENG, Yang KE, Ling YUAN, Peng LIU
2022, 1(1): 3-10. doi: 10.11910/j.issn.2791-3937.2022.20220001
[Abstract](557) [FullText HTML] (274) [PDF 1438KB](39)
5
Clinical Diagnosis and Treatment Recommendations for Immune Checkpoint Inhibitor-Associated Myocarditis
Yan WANG, Huiyong CHEN, Jinyi LIN, Jiahui CHEN, Yuhong ZHOU, Yingmei ZHANG, Hongwei ZHANG, Wei ZHU, Jie HU, Gang ZHAO, Xiangdong YANG, Shisuo DU, Xiaoyu LI, Guoming SHI, Jie CUI, Wei WU, Jing LI, Chi ZHANG, Cong WANG, Rongle LIU, Zheng LI, Chunhui WANG, Leilei CHENG, Junbo GE
2022, 1(3): 123-143. doi: 10.11910/j.issn.2791-3937.2022.20220018
[Abstract](506) [FullText HTML] (244) [PDF 1442KB](72)
6
Research progress of circular RNAs in drug resistance of liver cancer
Zhifan ZUO, Tao HAN
2022, 1(1): 32-38. doi: 10.11910/j.issn.2791-3937.2022.20210002
[Abstract](360) [FullText HTML] (167) [PDF 1286KB](26)
7
Expert Guidance on the Overall Management of Liver Cancer During the COVID-19 Pandemic
Huichuan SUN, Xinrong YANG, Zhiping YAN, Zhenggang REN, Rong LIU, Lan ZHANG, Yang XU, Yifeng HE, Zihan ZHANG, Jia FAN, Jian ZHOU
2022, 1(2): 49-55. doi: 10.11910/j.issn.2791-3937.2022.20220011
[Abstract](338) [FullText HTML] (160) [PDF 1286KB](39)
8
Combined Transcranial and Endoscopic Endonasal Approach for Resecting a Giant Intracranial and Extracranial Communicating Meningioma: A Case Report
Ye GU, Kai XUE, Quan LIU, Huankang ZHANG, Hongmeng YU
2022, 1(3): 167-171. doi: 10.11910/j.issn.2791-3937.2022.20220026
[Abstract](335) [FullText HTML] (157) [PDF 5054KB](7)
9
Brain Metastasis of Non-small-cell Lung Cancer
Tao JIANG, Shengxiang REN, Caicun ZHOU
2022, 1(1): 24-31. doi: 10.11910/j.issn.2791-3937.2022.20220002
[Abstract](324) [FullText HTML] (156) [PDF 1441KB](25)
10
Novel agents for multiple myeloma with extramedullary disease
Feifei CHEN, Aziguli MAIHEMAITI, Wenjing WANG, Peng LIU
2022, 1(2): 107-115. doi: 10.11910/j.issn.2791-3937.2022.20220013
[Abstract](292) [FullText HTML] (137) [PDF 1339KB](40)
11
Targeting Metabolism to Improve CAR-T Cell Immunotherapy
Xinlei HOU, Jian WANG
2022, 1(2): 100-106. doi: 10.11910/j.issn.2791-3937.2022.20220015
[Abstract](284) [FullText HTML] (133) [PDF 1813KB](24)
12
A Case Report: Severe Bullous Skin Reaction Induced by Anti-PD-1 Antibody (Toripalimab) Therapy in a Patient with Thymic Carcinoma
Chong TENG, Xiaowei SONG, Chengjuan FAN, Yashuang ZHAO, Lina DU, Siqi MAN, Yuanyuan HU, Zhengjun JIANG, Tao XIN
2022, 1(3): 172-175. doi: 10.11910/j.issn.2791-3937.2022.20220025
[Abstract](275) [FullText HTML] (41) [PDF 4980KB](8)
13
Artificial Intelligence in Neuro-oncology: Friend or Foe of Neurosurgeons?
Zhenyu GONG, Maximilian SCHWENDNER, Tao XU
2022, 1(1): 39-46. doi: 10.11910/j.issn.2791-3937.2022.20210003
[Abstract](265) [FullText HTML] (124) [PDF 1867KB](15)
14
Radiation-induced Oral Mucositis is a Critical Dilemma for Patients and Physicians During Radiotherapy for Nasopharyngeal Carcinoma
Zhifeng WU, Bingliang WANG, Xu ZHOU, Bei XU, Zhaochong ZENG
2022, 1(2): 95-99. doi: 10.11910/j.issn.2791-3937.2022.20220016
[Abstract](264) [FullText HTML] (128) [PDF 1271KB](35)
15
Comparison of Capillary and Venous Glucose Concentrations: A Real-world Study in Patients Undergoing Fluorodeoxyglucose–positron Emission Tomography
Ha WU, Guobing LIU, Yibo HE, Zhe ZHENG, Hongcheng SHI
2022, 1(3): 144-148. doi: 10.11910/j.issn.2791-3937.2022.20220019
[Abstract](255) [FullText HTML] (124) [PDF 1416KB](19)
16
Why a P value <0.05 does not necessarily mean statistical significance: controversy over overall survival results of the ORIENT-11 trial
Fei LIANG
2022, 1(1): 47-48. doi: 10.11910/j.issn.2791-3937.2022.20220003
[Abstract](218) [FullText HTML] (101) [PDF 1200KB](11)
17
Radiation-associated Angiosarcoma After Postoperative Adjuvant Radiotherapy for Cervical Cancer: A Case Report and Review of Published Reports
Yayu HUANG, Jing SUN, Genlai LIN, Guifen MA
2022, 1(2): 116-121. doi: 10.11910/j.issn.2791-3937.2022.20220009
[Abstract](218) [FullText HTML] (100) [PDF 5276KB](31)
18
Immune Checkpoint Inhibitor-induced Immune-mediated Hepatitis in A Lung Cancer Patient Undergoing Long-term Immunotherapy: A Case Report
Tengteng ZHANG, Yan ZHANG, Yiyin ZHANG
2022, 1(3): 176-181. doi: 10.11910/j.issn.2791-3937.2022.20220023
[Abstract](217) [FullText HTML] (106) [PDF 2039KB](10)
19
Nomogram to Predict Prognosis of Patients with Gastric Cancer after Radical Gastrectomy
Zhaorui LIU, Xiaona LIU, Wei XIE, Zhe YAN, Lu ZHAN, Ying LIU, Jiangbo HAN, Mingming NIE, Lei LIU, Hui CAI, Kai YIN
2022, 1(2): 66-80. doi: 10.11910/j.issn.2791-3937.2022.20220017
[Abstract](215) [FullText HTML] (103) [PDF 1704KB](24)
20
18F-FDG PET/MR Imaging for Evaluating of Obstructive Jaundice: Chinese Expert Consensus
Lifang PANG, Yushen GU, Zhi YANG, Zhifang WU, Wei FAN, Xiaohua ZHU, Jun ZHAO, Changjiu ZHAO, Xuemei WANG, Yongju GAO, Li HUO, Yi MO, Meiyun WANG, Jie LU, Lingzhi HU, Zheng ZHANG, Feng WANG, Xuemei DU, Yue CHEN, Jianjun LIU, Zhaoping CHENG, Yunlong LOU, Shuzhan YAO, Rong XU, Sijin LI, Hongcheng SHI
2022, 1(2): 56-65. doi: 10.11910/j.issn.2791-3937.2022.20220014
[Abstract](165) [FullText HTML] (22) [PDF 7197KB](38)
  • First
  • Prev
  • 1
  • 2
  • Last
  • Total:2
  • To
  • Go

Contacts

Supported by: Beijing Renhe Information Technology Co. Ltd